Ming-Lung Yu

Ming-Lung Yu

Professor, Faculty of Medicine,
College of Medicine,Kaohsiung Medical University, Kaohsiung, Taiwan
Vice Superintendent, Kaohsiung Medical University Hospital
Hepatobiliary Division, Department of Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st Rd, Kaohsiung 807, Taiwan

Get in Touch

Email: d780178@kmu.edu.tw

Education

1989
M.D., Faculty of Medicine,
College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
 
2000
Ph.D. Graduate Institute of Medical Science, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
 

Hospital Appointments

1994 - now
Attending Physician, Division of Hepatology, Department of Medicine, Kaohsiung Medical University Hospital
 
1994 - now
Attending Physician, Department of Preventive Medicine, Kaohsiung Medical University Hospital
 
1994 - now
Attending Physician, Department of Occupational Medicine, Kaohsiung Medical University Hospital
 
1998 - 2003
Attending Physician, Department of Medicine, Kaohsiung Municipal Hsiao Kang Hospital
 
1998 - 2003
Attending Physician, Department of Occupational Medicine, Kaohsiung Municipal Hsiao Kang Hospital
 
2010 - 2012
Superintendent, Kaohsiung Municipal Ta-Tung Hospital
 
2012 - now
Vice Superintendent, Kaohsiung Medical University Hospital
 

Other Professional Positions

1996 - 1998
Member of the Medical Information Technology and Development Committee, Kaohsiung Medical University Hospital
 
1998 - 2003
Chief, Department of Occupational Medicine, Kaohsiung Municipal Hsiao Kang Hospital
 
1998 - 2002
Member of the Radiation Safety Committee, Kaohsiung Municipal Hsiao Kang Hospital
 
1999 - now
Deputy Secretary General, Taiwan Liver Research Foundation
 
2001 - 2002
Director of the Occupational Safety and Health Committee, Kaohsiung Municipal Hsiao Kang Hospital
 
2003 - 2005
Member of the Kaohsiung City Committee of Occupational Disease Identification
 
2003 - 2009
Secretary of Medical Affairs, Kaohsiung Medical University Hospital
 
2003 - 2009
Director, Department of Preventive Medicine, Kaohsiung Medical University Hospital
 
2007 - 2009
Professional Consumer of Drug Advisory Committee, Department of Health, Executive Yuan, ROC.
 
2009 - 2009
Chairman of preparatory committee, Kaohsiung Municipal Ta-Tung Hospital
 
2010 - 2011
Secretary General, Taiwan Association for Study of Liver Disease
 

Honors and Awards

1994
Best Chief Resident, Department of Medicine,
Kaohsiung Medical University Hospital
 
2005
Best clinical research article, annual meeting of Society of Internal Medicine, R.O.C., Taipei
 
2006
Outstanding Research Article Award, Kaohsiung Medical University, 2005
 
2006
Best Research Performance Index Award,
Kaohsiung Medical University, 2005
 
2007
Outstanding Research Article Award, Kaohsiung Medical University, 2006
 
2007
Best Research Performance Index Award,
 
2008
Best Poster Award, 18th Conference of the APASL in Seoul,
 
2008
Outstanding Research Article Award, Kaohsiung Medical University, 2007
 
2008
Best Research Performance Index Award,
Kaohsiung Medical University, 2007
 
2009
Outstanding Research Article Award, Kaohsiung Medical University, 2008
 
2009
Best Research Performance Index Award,
Kaohsiung Medical University, 2008
 
2010
Best Poster Award, 7th Single Topic Conference of the APASL in Chiba.
 
2010
Best Research Performance Index Award, Kaohsiung Medical University.
 
2011
Outstanding Research Article Award, Kaohsiung Medical University, 2010
 
2011
Best Research Performance Index Award, Kaohsiung Medical University
 
2012
Best Research Article, Taiwan Liver Research Foundation, 2012
 
2012
Outstanding Research Article Award, Kaohsiung Medical University, 2011
 
2012
Best Research Performance Index Award, Kaohsiung Medical University
 
2012
Kao-Xing Award, Kaohsiung Medical Association
 
2012
Outstanding Research Award, National Science Council, 2012
 

Publications

  1. Liao, Y. C., W. W. Chou, Y. N. Li, S. C. Chuang, W. Y. Lin, B. V. Lakkakula, M. L. Yu and S. H. Juo. "Apelin Gene Polymorphism Influences Apelin Expression and Obesity Phenotypes in Chinese Women." Am J Clin Nutr 94, no. 3 (2011): 921-8
  2. Liao, Y. C., Y. S. Wang, Y. C. Guo, K. Ozaki, T. Tanaka, H. F. Lin, M. H. Chang, K. C. Chen, M. L. Yu, S. H. Sheu and S. H. Juo. "Brap Activates Inflammatory Cascades and Increases the Risk for Carotid Atherosclerosis." Mol Med 17, no. 9-10 (2011): 1065-74.
  3. Dai, C. Y., M. L. Yeh, J. F. Huang, W. L. Chuang and M. L. Yu. "Insurance Status and Treatment Candidacy of Patients with Hepatitis C: Taiwanese Patients Are Luckier." Hepatology 53, no. 4 (2011): 1399; author reply 1400.
  4. Yu, M. L., C. H. Liu, C. F. Huang, T. C. Tseng, J. F. Huang, C. Y. Dai, Z. Y. Lin, S. C. Chen, L. Y. Wang, S. H. Juo, W. L. Chuang and J. H. Kao. "Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin." PLoS One 7, no. 12 (2012): e52048.a
  5. Huang, C. F., M. L. Yeh, J. F. Huang, J. F. Yang, M. Y. Hsieh, Z. Y. Lin, S. C. Chen, L. Y. Wang, E. Hsi, S. H. Juo, C. Y. Dai, W. L. Chuang and M. L. Yu. "Host Interleukin-28b Genetic Variants Versus Viral Kinetics in Determining Responses to Standard-of-Care for Asians with Hepatitis C Genotype 1." Antiviral Res 93, no. 2 (2012): 239-44.
  6. Hsieh, M. H., W. Y. Lin, H. H. Chien, L. H. Chien, C. K. Huang, J. F. Yang, N. C. Chang, C. F. Huang, C. L. Wang, W. L. Chuang, M. L. Yu, C. Y. Dai and C. K. Ho. "Waist Circumference, Body Mass Index, Serum Uric Acid, Blood Sugar, and Triglyceride Levels Are Important Risk Factors for Abnormal Liver Function Tests in the Taiwanese Population." Kaohsiung J Med Sci 28, no. 9 (2012): 470-6.
  7. Huang, J. F., M. L. Yu, C. F. Huang, S. H. Juo, C. Y. Dai, M. Y. Hsieh, N. J. Hou, M. L. Yeh, M. H. Hsieh, J. F. Yang, Z. Y. Lin, S. C. Chen, S. J. Shin and W. L. Chuang. "The Outcomes of Glucose Abnormalities in Pre-Diabetic Chronic Hepatitis C Patients Receiving Peginterferon Plus Ribavirin Therapy." Liver Int 32, no. 6 (2012): 962-9.
  8. Huang, C. F., C. Y. Dai, M. L. Yeh, J. F. Huang, C. I. Huang, M. Y. Hsieh, Z. Y. Lin, S. C. Chen, L. Y. Wang, S. H. Juo, W. L. Chuang, Y. C. Lin and M. L. Yu. "Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients." PLoS One 8, no. 3 (2013): e58882.
  9. Huang, C. I., C. F. Huang, J. F. Huang, C. Y. Dai, M. L. Yeh, M. Y. Hsieh, Z. Y. Lin, S. C. Chen, L. Y. Wang, M. L. Yu and W. L. Chuang. "The Treatment Efficacy of Pegylated Interferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Mixed Genotype 1/2 Infection." J Gastroenterol Hepatol, (2013).
  10. Huang, J. F., M. L. Yu, C. Y. Dai and W. L. Chuang. "Glucose Abnormalities in Hepatitis C Virus Infection." Kaohsiung J Med Sci 29, no. 2 (2013): 61-8.
  11. Yang, H. C., C. L. Chen, Y. C. Shen, C. Y. Peng, C. J. Liu, T. C. Tseng, T. H. Su, W. L. Chuang, M. L. Yu, C. Y. Dai, C. H. Liu, P. J. Chen, D. S. Chen and J. H. Kao. "Distinct Evolution and Predictive Value of Hepatitis B Virus Precore and Basal Core Promoter Mutations in Interferon-Induced Hepatitis B E Antigen Seroconversion." Hepatology 57, no. 3 (2013): 934-43.
  12. Chuang, W. L. and M. L. Yu. "Host Factors Determining the Efficacy of Hepatitis C Treatment." J Gastroenterol 48, no. 1 (2013): 22-30.
  13. Dai, C. Y., W. L. Chuang and M. L. Yu. "A 24-Week Peg-Interferon Alpha-2b Versus a 12-Week Peg-Interferon Alpha-2b Alone or with Ribavirin for Patients with Acute Hepatitis C." Hepatology, (2014).
  14. Dai, C. Y., W. L. Chuang and M. L. Yu. "Variants of the Inosine Triphosphate Pyrophosphatase Gene and Relapse Risk Following Treatment for Hcv Genotype 2/3." Hepatology, (2014).
  15. Hsi, E., C. F. Huang, C. Y. Dai, S. H. Juo, W. W. Chou, J. F. Huang, M. L. Yeh, Z. Y. Lin, S. C. Chen, L. Y. Wang, W. L. Chuang and M. L. Yu. "Peripheral Blood Mononuclear Cells Microrna Predicts Treatment Outcome of Hepatitis C Virus Genotype 1 Infection." Antiviral Res, (2014).
  16. Yu, M. L., C. Y. Dai, C. F. Huang, J. J. Lee, M. L. Yeh, S. M. Yeh, H. T. Kuo, J. F. Huang, J. M. Chang, H. C. Chen, S. H. Juo, S. J. Hwang, W. L. Chuang and Formosa-Like group. "High Hepatitis B Virus Surface Antigen Levels and Favorable Interleukin 28b Genotype Predict Spontaneous Hepatitis C Virus Clearance in Uremic Patients." J Hepatol 60, no. 2 (2014): 253-9
  17. Huang, C. F., M. L. Yeh, P. C. Tsai, M. H. Hsieh, H. L. Yang, M. Y. Hsieh, J. F. Yang, Z. Y. Lin, S. C. Chen, L. Y. Wang, C. Y. Dai, J. F. Huang, W. L. Chuang and M. L. Yu. "Baseline Gamma-Glutamyl Transferase Levels Strongly Correlate with Hepatocellular Carcinoma Development in Non-Cirrhotic Patients with Successful Hepatitis C Virus Eradication." J Hepatol, (2014).
  18. Jeng, J. E., M. F. Tsai, H. R. Tsai, L. Y. Chuang, Z. Y. Lin, M. Y. Hsieh, S. C. Chen, W. L. Chuang, L. Y. Wang, M. L. Yu, C. Y. Dai and J. F. Tsai. "Impact of Chronic Hepatitis B and Hepatitis C on Adverse Hepatic Fibrosis in Hepatocellular Carcinoma Related to Betel Quid Chewing." Asian Pac J Cancer Prev 15, no. 2 (2014): 637-42.

 

中心發表之文獻

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19

Pubmed source Author: Tzu-Chuan Ho, Yung-Hsuan Wang, Yi-Ling Chen, Wan-Chi Tsai, Che-Hsin Lee, Ku...

2021-02-17

Honeysuckle aqueous extracts induced let-7a suppress EV71 replication and pathogenesis in vitro and in vivo, and predict-able to inhibit SARS-CoV-2

Pubmed source Author: Ying-Ray Lee , Chia-Ming Chang , Yuan-Chieh Yeh , Chi-Ying F Huang , Feng-M...

2021-02-16

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy

Pubmed source Author: Yeh ML, Kuo HT, Huang CI, Huang CF, Hsieh MY, Liang PC, Lin IH, Hsieh MH, L...

2021-02-10

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals

Pubmed source Author: Lin CP, Liang PC, Huang CI, Yeh ML, Hsu PY, Hsu CT, Wei YJ, Liu TW, Hsieh M...

2021-02-04

Positive fecal immunochemical test strongly predicts adenomas in younger adults with fatty liver and metabolic syndrome

Pubmed source Author: Yeh JH, Lin CW, Wang WL, Lee CT, Wu TC, Hsiao PJ, Tseng CH, Wang JY*(王照元) A...

2021-02-03

Role of the NLRP3 Inflammasome: Insights into Cancer Hallmarks

Pubmed source Author: Lin TY, Tsai MC, Tu W, Yeh HC, Wang SC, Huang SP*(黃書彬), Li CY*(李佳陽) Abstras...

2021-02-03

近期焦點

恭賀本中心執行長榮獲「中華民國癌症醫學會癌症醫學終身成就獎」

恭賀本中心執行長獲中華民國癌症醫學會癌症醫學終身成就獎

2025-05-14

恭賀本中心執行長榮獲「經濟部國家產業創新獎」

恭賀本中心陳立宗執行長獲經濟部國家產業創新獎

2025-05-14

Go to top